<DOC>
	<DOCNO>NCT00334360</DOCNO>
	<brief_summary>The purpose research determine combination buspirone dexmedetomidine effective treatment induce therapeutic hypothermia . The design study include four study day do random order . The day follow : 1 ) Control ( drug ) ; 2 ) Buspirone 60 mg orally ; 3 ) Dexmedetomidine ( deliver computer-controlled IV infusion target plasma concentration 0.6 ng/ml ) ; , 3 ) combination buspirone 60 mg dexmedetomidine ( target plasma concentration 0.6 ng/ml ) . 20 cm-long catheter insert cubital vein use standard aseptic technique In addition PIC line catheter , simple peripheral catheter insert arm drug administration . Throughout study period , mean-skin temperature maintain 31°C adjusting temperature circulate water ( Cincinnati Sub-Zero , Cincinnati , OH ) forced-air warmer ( Augustine Medical , Inc. , Eden Prairie , MN ) . Furthermore , back , upper-body , lower-body individually maintain designate skin temperature . Lactated Ringer 's solution cool ≈3°C infused via PIC-line rate sufficient decrease tympanic membrane temperature ≈1.5°C/h . Fluid administer long oxygen consumption electromyographic intensity ( see ) continue increase total 5 liter fluid give . Heart rate measure continuously use electrocardiogram ; blood pressure determine oscillometrically 5 min interval ankle . In case heart rate and/or blood pressure change unexpectedly ( 30 % baseline ) , study stop volunteer re-warmed immediately .</brief_summary>
	<brief_title>Dexmed/Buspirone Synergism Shivering</brief_title>
	<detailed_description />
	<mesh_term>Hypothermia</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<criteria>1840 year normal weight ( BMI &lt; 35 ) healthy obese ( BMI &gt; 35 ) take drug thyroid disease , dysautonomia , Raynaud 's syndrome severe claustrophobia</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>